Funds and ETFs Guilin Sanjin Pharmaceutical Co., Ltd.

Equities

002275

CNE100000DY9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
14.3 CNY +0.92% Intraday chart for Guilin Sanjin Pharmaceutical Co., Ltd. +3.55% -1.31%

ETFs positioned on Guilin Sanjin Pharmaceutical Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.67% -
Guilin Sanjin Pharmaceutical Co., Ltd is a China-based company, principally engaged in the research, production and distribution of Chinese patent medicines, as well as distribution of products. The Company's main products portfolio consists of watermelon frost series, including watermelon frost lozenge, guilin watermelon frost and watermelon frost throat lozenge, mainly used for treatment of throat and mouth diseases; sanjin tablets, mainly used for treatment of urinary system infection, as well as naomaitai capsules, mainly used for treatment of cardiovascular and cerebrovascular diseases. It distributes its products within domestic market and to overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.3
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002275 Stock
  4. Funds and ETFs Guilin Sanjin Pharmaceutical Co., Ltd.